feed,title,long_url,short_url
Benzinga,AstraZeneca - Ionis Eplontersen Achieves Positive Data In Rare Disease Trial,https://benzinga.com/general/biotech/22/06/27789434/astrazeneca-ionis-eplontersen-achieves-positive-data-in-rare-disease-trial,https://bit.ly/3xAAPty
Benzinga,Edgewise's Dystrophy Candidate Lowers Muscle Damage Biomarkers,https://benzinga.com/general/biotech/22/06/27790459/edgewises-dystrophy-candidate-lowers-muscle-damage-biomarkers,https://bit.ly/3OxIC2u
